Mediscience Tecnology Corp.
Home   About   Investor Relations   News   Intellectual Property   Products   Alliances
  Executive Management
 

Corporate Profile

 
 

Executive
Management

 
 

Board of
Directors

 
 

Investor
Presentations

 
 

Stock Price

 
 

SEC Filings

 
 

Sarbanes Compliance

 

Management

CEO and Chairman – Peter Katevatis
Peter Katevatis Esq. Co-Founder of Mediscience with Dr. Robert Alfano has served as Chairman of the Board of Directors / legal counsel since 1993. Admitted to the PA. NY, NJ and DC bar associations. .Mr. Katevatis was a trustee of the New Jersey State's Police and Fireman Retirement Pension Fund 1990-98 and served as a member of the State of New Jersey Investment Council from 1990 until December, 1992. He serves as a judicial arbitrator for the American Arbitration Association and the National Association of Securities Dealers (NASD). Mr. Katevatis is also a long-time member of the National District Attorney's Association and a member of the New York Academy of Science.

COO and President – Michael Engelhart
20-year track record as a successful entrepreneur and senior executive in sales & marketing, business/corporate development, growing distribution channels, and product development. Michael has served as President, COO and board member for Mediscience Technology for two years. Mr. Engelhart is experienced in management and consulting of several successful companies in the healthcare field including; WebMD, Vitabiotics, Ltd, Max.Md, Sylkworks, Inc., I2MD, LLC and Den Ventures, LLC. Mr. Engelhart was the President and CEO of THM Group, LLC, a firm providing strategic consulting services in the areas of business strategy, development and operations and product branding, launch and development; client list includes, Consolidated Edision, Orange and Rockland Utilties, KN Energy, Reeves International, Channel Space Entertainment, Neptune Plastics Manufacturing and SAVA Industries.

CFO– Frank Bennick, CPA
Proven track record of management and supervision of an accounting staff of 50+. Experience as a Chief Financial Officer with a specific expertise in all phases of corporate accounting re: public/private companies including filing of Forms 10-Q, 10-K, financial statements, internal controls and budgets. Mr. Bennick is presently a CPA and partner at Cust, Dori & Bennick. Mr. Bennick was previously employed as a CPA with J.H. Cohn & Co. and a Senior Accountant at Arnper, Ploitziner & Mattia.

Chief Medical Officer Stephene Lubicz, M.D
Chief Medical Officer Dr. Stephane Lubicz consultant with Mediscience on the clinical aspects of the CD Ratiometer project. -- has over 20 years of business and private practice experience in gynecology oncology. Responsible for coordinating the management of the clinical development of the Company's platform projects with focus on implementing clinical study protocols, including those for projects in the U.S as well as Mexico and South/Central America. He received his Bachelor of Science Degree, Cum Laude from Free University, Brussels, Belgium and his M.D. degree fromt Free University as well. In addition to his active role as a practicing New York City physician, specializing in Gynecologic Oncology, his professional experience covers a broad range of activities in the Research and Development of pharmaceutical products. Specifically, this includes United States consultant to B & A Inc., a company that operates as a service group for coordinating and organizing clinical trials (Phase I, II, III) in Mexico and throughout Latin America . As Medical Director, Clinical Development Oncology for Daiichi Pharmaceutical Corp. he was responsible for coordinating and the management of the clinical development of the Company's drug projects with focus on implementing clinical study protocols, including those for projects in the U.S as well as Mexico and South/Central America. He has been an active participant in the working as a consultant with Mediscience on the clinical aspects of the CD Ratiometer project.

Chief Scientific Advisor– Robert R. Alfano, Ph.D.
Co-Founder of Mediscience with Mr. Katevatis. Distinguished Professor of Science and Engineering, CCNY. Currently a Distinguished Professor of Science and Engineering, he serves as Director of the Institute for Ultrafast Spectroscopy and Lasers. Dr. Alfano is the Director of the New York State Center of Advanced Technology for Ultrafast Photonic Materials and Applications, the NASA Institutional Research Program, and the DOE Center of Excellence for Laser Imaging in Medicine.

Regulatory Affairs– Dr. Robert Schiff / Schiff & Companff
Foundedin 1982, Schiff & Company is an international Regulatory Affairs and Clinical Research Organization. Senior Management personnel each have more than 25 years experience in the health care and regulatory fieldsfor drugs, biologics, diagnostics, and devices. Schiff & Company represents both domestic and international organizations to the FDA and to foreign regulatory bodies and writes all appropriate regulatory filings.

Mediscience Audit Committee
John Kennedy has been chairman of the AuditCommittee since 2000 and Vice President Secretary and director of the Company since 1982. Mr. Kennedy is Chairman of the Board and CEO of Pepco Manufacturing Co., a 30 yr fabricator for the electronics industry located in Somerdale, New Jersey. Mr. Kennedy served as director and member of the Audit Committee of First Peoples Bank of New Jersey and as a member of its executive board until 1994 when First Peoples Bank was acquired by Corestates Bank .

Schiff & Company

Clinical Research and Regulatory Affairs

  • Schiff & Company, founded in 1982, is an international Regulatory Affairs and Clinical Research Organization. Senior Management personnel each have more than 25 years experience in the health care and FDA regulatory fields.

  • Schiff & Company will conduct and monitor clinical studies for Mediscience diagnostic devices. Schiff represent both domestic and international organizations to the FDA and to foreign regulatory bodies. Will write all appropriate regulatory filings.

  • Schiff staff plans regulatory strategy, prepares clinical development plans, performs GMP and validation audits, writes SOP’s and conducts due diligence.

 
     Copyright © 2004 Mediscience Technology Corp. Contact Us